Opportunities Amid Stock Price Correction? Decoding Eli Lilly’s Moat and Growth Potential Oct 28, 2025 Life Science
It’s the Right Time for Vertex Pharmaceuticals to Look for Growth Drivers Beyond Tech Stocks Oct 27, 2025 Life Science
BioAge Labs Soars 46% on Novel Weight-Loss Drug Prospects, Yet Clinical Hurdles Remain Oct 26, 2025 Life Science
Why Can Eli Lilly Ignore Tariff Threats? Domestic Production Capacity and Gene Therapy Are Key Oct 24, 2025 Life Science
Navigating the Low Point: Can Moderna’s Innovative Pipeline Illuminate the Path Forward? Oct 23, 2025 Life Science
Healthcare Services Group’s Earnings Soar, Stock Price Surges Nearly 14% in a Single Day Oct 23, 2025 Life Science
Nvidia-Backed AI Biotech Recursion Soars 25% in a Month: Time to Buy or Beware? Oct 21, 2025 Life Science
Goldman’s 2026 Playbook: Ride Dividend Growth in Healthcare, Utilities, Industrials Oct 21, 2025 Energy, Life Science
Tempus AI Stock Lifted by Analyst Optimism and Subsidiary’s Tech Breakthrough Oct 20, 2025 Life Science, Technology
Why Should We Pay Attention to Temporarily Setback-Stricken Novo Nordisk and Merck? Oct 20, 2025 Life Science
Who Will Dominate the Next Generation of Weight-Loss Drugs? The Fierce Battle Between Eli Lilly and Viking Oct 16, 2025 Life Science
Expanding New Frontiers in Women’s Health, Hims & Hers Market Cap Soars in a Single Day Oct 15, 2025 Life Science
Driven by the Engine of Innovation, Eli Lilly Leads a New Era in Healthcare Oct 14, 2025 Life Science
